Catalyst Wire Dossier Catalyst Wire Dossier

18F-Fluoroazomycin Arabinoside (18F-FAZA)

Fluoroazomycin Arabinoside
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 18F-Fluoroazomycin Arabinoside (18F-FAZA), covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: 18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer [NA]

See pricing